To determine the role of SET8 in AKI, we examined the effect of SET8 inhibition on cisplatin-induced AKI in a mouse model using UNC0379, a highly selective inhibitor of SET8 [18–20]. The gene discussed is KMT5A; the disease is acute kidney injury.